Suchergebnisse - "Girard, Pierre-Marie"

PubPharm (492)

1

Plasma concentrations of antiretroviral drugs in a successful 4-days-a-week maintenance treatment strategy in HIV-1 patients (ANRS 170-Quatuor trial)

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Abe, E. | Landman, R. | Assoumou, L. | +8

2

The AsiDNA™ decoy mimicking DSBs protects the normal tissue from radiation toxicity through a DNA-PK/p53/p21-dependent G1/S arrest

enthalten in: NAR cancer | 2024

von Sesink, A. | Becerra, M. | Ruan, J. | +9

3

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19 : an analysis of data from a consortium of prospective cohort studies

enthalten in: The lancet. HIV | 2024

von Sacks-Davis, R. | van Santen, D. | Boyd, A. | +104

4

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1 : week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

enthalten in: The lancet. HIV | 2024

von Orkin, C. | Molina, J. | Cahn, P. | +112

5

Cohort Profile : International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

enthalten in: International journal of epidemiology | 2024

von van Santen, D. | Stewart, A. | Doyle, J. | +101

6

Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir + lamivudine simplification in the ANRS 167 LAMIDOL trial

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Mazouz, F. | Bertine, M. | Coppée, R. | +43

7

Feasability and effectiveness of scaling up hepatitis-C treatment in West and Central Africa: the TAC ANRS 12311 clinical trial

enthalten in: ResearchSquare.com | 2023

von Lacombe, K. | Moh, R. | Chazallon, C. | +20

8

Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR) : substudies of reservoirs and ultrasensitive drug resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Lambert-Niclot, S. | Abdi, B. | Bellet, J. | +113

9

Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection : 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Overton, E. | Richmond, G. | Rizzardini, G. | +22

CommentIn: Clin Infect Dis. 2023 May 3;76(9):1655-1657. - PMID 36660823

10

Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography : A European Multicenter Prospective Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Lemoine, M. | Assoumou, L. | Girard, P. | +26

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[50]